Primary medical therapy for BRAF
V600E
-mutant melanoma brain metastases-is this good enough?
Lancet Oncol
.
2017 Sep;18(9):e508.
doi: 10.1016/S1470-2045(17)30633-2.
Authors
Tim J Kruser
1
,
Michael A Vogelbaum
2
Affiliations
1
Department of Radiation Oncology, Northwestern University Feinberg School of Medicine, Chicago, IL 60661, USA. Electronic address: tkruser@nm.org.
2
Department of Neurological Surgery, The Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center, Cleveland Clinic, Cleveland, OH, USA.
PMID:
28884696
DOI:
10.1016/S1470-2045(17)30633-2
No abstract available
Publication types
Letter
Comment
MeSH terms
Brain Neoplasms
Humans
Melanoma*
Mutation
Proto-Oncogene Proteins B-raf / genetics*
Skin Neoplasms
Substances
Proto-Oncogene Proteins B-raf